Endothelial-cell viability and redox readouts
Cell-based study · Human umbilical vein endothelial cells (HUVECs), with normal-cell controls and LPS-associated injury [1]
Typhaneoside increased the MTT viability signal at 0.56–70 μmol/L relative to the injury control (reported p<0.01); 0.11 μmol/L had no detected benefit. Normal-cell viability remained >90% over 0.11–70 μmol/L. At 70 μmol/L, MDA and NO were lower and SOD activity higher than in the injury control. These assays do not establish a direct molecular target or distinguish increased proliferation from altered MTT metabolism.
| Endpoint | Reported result | Reference |
|---|---|---|
| MTT signal relative to untreated normal cells | relative viability 58.35% in the injury control; improvement at 0.56–70 μmol/L (p<0.01); no effect at 0.11 μmol/L | [1] |
| MDA at 70 μmol/L typhaneoside | MDA concentration 1.91 ± 0.10 nmol/mL; p<0.05 versus injury control | [1] |
| NO-associated nitrite readout at 70 μmol/L typhaneoside | NO concentration 14.64 ± 0.08 μmol/L; p<0.01 versus injury control | [1] |
| SOD activity at 70 μmol/L typhaneoside | SOD activity 22.94 ± 2.48 U/mL; p<0.01 versus injury control | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- 0.11, 0.56, 2.8, 14 and 70 μmol/L for viability; 2.8, 14 and 70 μmol/L for redox readouts
- Exposure duration
- MTT compound exposure: 24 h. Exact compound-versus-injury timing for all redox measurements is not clearly specified.
- Method
- Cell exposure; MTT and biochemical kit measurements
- Vehicle
- DMSO identified as solvent; final treatment percentage and explicit matched vehicle control are not stated.
- Co-treatment
- Injury stimulus used for challenged-cell comparisons; I3ON was a separate comparator, not a combination.
- Reported limits
- Sequence of compound and injury exposure is unclear. Figure n=5 is not explicitly defined as independent biological replicates. No direct target, target engagement or mechanistic rescue experiment.
Methods and source locations
Compound reported in the paper: Typhaneoside
Applies to the named research compound; does not validate an Adooq lot or transfer extract results to purified typhaneoside.
Materials and methods: Materials and reagents, MTT assay, Measurement of MDA/NO/SOD, Statistical analysis; Results and Figures 3–5
MTT signal relative to untreated normal cells: MTT; Figure 4 mean ± SD, n=5; independence of replicates unspecified — Results: Viability of LPS-induced HUVECs; Figure 4 and caption
MDA at 70 μmol/L typhaneoside: Thiobarbituric acid assay; mean ± SD, n=5 — Results: Measurement of MDA, NO and SOD; Figure 5 MDA panel/caption
NO-associated nitrite readout at 70 μmol/L typhaneoside: Griess nitrite assay; mean ± SD, n=5 — Results: Measurement of MDA, NO and SOD; Figure 5 NO panel/caption
SOD activity at 70 μmol/L typhaneoside: Xanthine/xanthine oxidase assay; mean ± SD, n=5 — Results: Measurement of MDA, NO and SOD; Figure 5 SOD panel/caption